SCHEMBL7265455

SCHEMBL7265455

c1ccc(Cc2cccc(N3CCCCC3)c2)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.66
AGXT P21549 1/20 0.58
SLC6A2 P23975 1/20 0.52
SLC6A4 P31645 1/20 0.52
SLC6A3 Q01959 1/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
KDM4E B2RXH2 2/20 0.51
ALDH1A1 P00352 2/20 0.51
HPGD P15428 2/20 0.51
USP2 O75604 1/20 0.51
POLB P06746 1/20 0.51
MAPT P10636 1/20 0.51
BLM P54132 1/20 0.51
GAA P10253 1/20 0.49
HSD17B10 Q99714 1/20 0.49
CHKA P35790 4/20 0.47
L3MBTL3 Q96JM7 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
MBTD1 Q05BQ5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11851347 0.86 PRMT6 (0.62) PRMT6AGXTMEN1KMT2AKDM4E
SCHEMBL28198974 0.83 CHKA (0.56) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL5227564 0.81 SLC6A2 (0.48) PRMT6AGXTSLC6A2SLC6A4SLC6A3
SCHEMBL5301158 0.81 CHKA (0.58) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL11849101 0.80 PRMT6 (0.55) PRMT6AGXTSLC6A2SLC6A4SLC6A3
SCHEMBL16726976 0.80 PRMT6 (0.63) PRMT6AGXTMEN1KMT2AKDM4E
SCHEMBL5095800 0.80 AGXT (0.65) PRMT6AGXTMEN1KMT2AKDM4E
SCHEMBL15833077 0.80 PRMT6 (0.63) PRMT6AGXTMEN1KMT2AKDM4E
SCHEMBL6268645 0.80 PRMT6 (0.63) PRMT6AGXTMEN1KMT2AKDM4E
SCHEMBL113799 0.80 AGXT (0.65) PRMT6AGXTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0566142-A1 Inclusion complexes of optically active and racemic 1,4-dihydro pyridines with cyclodextrin derivates LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) 1993-10-20 EP claimed
EP-0207674-A2 1,4-Dihydropyridine derivatives, their preparation and their pharmaceutical use SANKYO COMPANY LIMITED (JP) 1987-01-07 EP claimed
JP-6100537-A None JP disclosed
US-5519012-A CALCIUM ANTAGONISTS, CARDIOVASCULAR DISORDERS LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, D.D., LJUBLJANA (SI) 1996-05-21 US disclosed
US-5519012-A CALCIUM ANTAGONISTS, CARDIOVASCULAR DISORDERS LEK, TOVARNA FARMACEVTSKIH IN KEMICNIH IZDELKOV, D.D., LJUBLJANA (SI) 1996-05-21 US disclosed
JP-H06100537-A INCLUSION COMPLEX OF OPTICALLY ACTIVE RACEMIC 1,4-DIHYDROPYRIDINE WITH METHYL-BETA-CYCLODEXTRIN OR OTHER CYCLODEXTRIN DERIVATIVE, PREPARATION OF OPTICALLY ACTIVE DIHYDROPYRIDINE AND ITS INCLUSION COMPLEX, MEDICINAL COMPOSITION CONTAINING SAME COMPLEX AND USE OF SAME COMPLEX LEK TOVARNA FARMACEVTSKIH 1994-04-12 JP disclosed
EP-0566142-A1 Inclusion complexes of optically active and racemic 1,4-dihydro pyridines with cyclodextrin derivates LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) 1993-10-20 EP disclosed
EP-0566142-A1 Inclusion complexes of optically active and racemic 1,4-dihydro pyridines with cyclodextrin derivates LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. (SI) 1993-10-20 EP disclosed
EP-0207674-A2 1,4-Dihydropyridine derivatives, their preparation and their pharmaceutical use SANKYO COMPANY LIMITED (JP) 1987-01-07 EP disclosed